Lanean...
Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
The growing emergence of drug-resistant bacterial strains is an issue to treat severe infections, and many efforts have identified new pharmacological agents. The inhibitors of β-lactamases (BLI) have gained a prominent role in the safeguard of beta-lactams. In the last years, new β-lactam–BLI combi...
Gorde:
| Argitaratua izan da: | Antibiotics (Basel) |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8300739/ https://ncbi.nlm.nih.gov/pubmed/34202609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10070769 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|